The civic record
Read. Follow. Verify.House Subcommittee Hearing on Drug Pricing Transparency
Record date · January 1, 2021
Track this bill to get notified when it advances a stage. One tap to stop, anytime.
What This Bill Does
The House Subcommittee on Health held a hearing on May 21, 2019, to discuss legislative proposals aimed at increasing transparency in drug pricing and reducing costs for consumers. The session included testimony from pharmaceutical industry representatives, medical organizations, and policy experts regarding several proposed bills.
This hearing reviewed legislative proposals that could change how drug manufacturers and pharmacy benefit managers disclose pricing and discount information, directly impacting the regulatory environment for pharmaceutical costs.
Who It Affects
Groups the bill's text affects, as described in the record. Being affected is not a position for or against it.
Pharmaceutical Manufacturers
The proposed legislation would require new disclosures regarding drug pricing and manufacturing.
Pharmacy Benefit Managers
The proposed legislation includes requirements for the public disclosure of drug discounts.
American Consumers
The legislative goals aim to influence the final costs of prescription drugs.
Key Facts
- The hearing was held on May 21, 2019, by the Subcommittee on Health of the Committee on Energy and Commerce.
- The hearing focused on four specific legislative proposals: H.R. 2064, H.R. 2069, H.R. 2087, and H.R. 2115.
- H.R. 2064 proposes amendments to title XI of the Social Security Act concerning manufacturers of drugs, devices, and biologicals.
- H.R. 2069 is titled the 'Stopping the Pharmaceutical Industry from Keeping drugs Expensive Act'.
Show all 7 facts
- H.R. 2087 is titled the 'Drug Price Transparency Act'.
- H.R. 2115 is titled the 'Public Disclosure of Drug Discounts Act'.
- Witnesses included representatives from the pharmaceutical industry, the Coalition of State Rheumatology Organizations, Families USA, Arnold Ventures, and the American Action Forum.
Frequently Asked Questions
What was the purpose of this hearing?
Which bills were discussed?
What else do you want to know?
News Coverage
Follow the record
Votes, people, money & the original sourceFull breakdown
Who this bill affects and the strongest case for and against it, written only from the bill’s own text.
Discoveries
Patterns POLISCOPE noticed across the record. These are observations to investigate, not conclusions.
Connected Entities
Sources
www.govinfo.gov
Analysis Score
0–100- Significance85How much this matters to a regular citizen
- Controversy60Intensity of disagreement among stakeholders
- Entertainment10Compellingness for a non-policy-wonk reader
- Buzz20Current news / social attention level
Publisher tools